SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $208,000 | -97.0% | 2,875 | -94.2% | 0.00% | -96.8% |
| Q3 2019 | $6,996,000 | -38.1% | 49,865 | -19.2% | 0.10% | -34.9% |
| Q2 2019 | $11,305,000 | +13.7% | 61,745 | -1.2% | 0.15% | +9.8% |
| Q1 2019 | $9,945,000 | +26.8% | 62,525 | -23.6% | 0.13% | +12.7% |
| Q4 2018 | $7,844,000 | -35.8% | 81,885 | -5.3% | 0.12% | -23.4% |
| Q3 2018 | $12,211,000 | -19.8% | 86,450 | -11.1% | 0.15% | -20.2% |
| Q2 2018 | $15,230,000 | +67.8% | 97,295 | +72.6% | 0.19% | +66.4% |
| Q1 2018 | $9,077,000 | +47.7% | 56,355 | +51.1% | 0.12% | +65.7% |
| Q4 2017 | $6,144,000 | +67.5% | 37,300 | -36.7% | 0.07% | +66.7% |
| Q3 2017 | $3,669,000 | -35.5% | 58,900 | -17.6% | 0.04% | -38.2% |
| Q2 2017 | $5,690,000 | +31.1% | 71,450 | +17.0% | 0.07% | +28.3% |
| Q1 2017 | $4,339,000 | +34.8% | 61,050 | -3.2% | 0.05% | +29.3% |
| Q4 2016 | $3,219,000 | +57.6% | 63,050 | +42.1% | 0.04% | +64.0% |
| Q3 2016 | $2,043,000 | -14.2% | 44,375 | -43.9% | 0.02% | +66.7% |
| Q2 2016 | $2,382,000 | +88.0% | 79,050 | +100.0% | 0.02% | -11.8% |
| Q1 2016 | $1,267,000 | -44.1% | 39,525 | +1.7% | 0.02% | -45.2% |
| Q4 2015 | $2,266,000 | +61.7% | 38,875 | +17.4% | 0.03% | +63.2% |
| Q3 2015 | $1,401,000 | -15.4% | 33,100 | +45.8% | 0.02% | -5.0% |
| Q2 2015 | $1,657,000 | +101.3% | 22,700 | +38.6% | 0.02% | +100.0% |
| Q1 2015 | $823,000 | – | 16,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |